Clinical Presentation of Inadvertent Intrathecal Vincristine Masquerading Guillain–Barre Syndrome

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Vincristine, a potent chemotherapeutic agent, is highly neurotoxic. If given intrathecally by accident it is almost always fatal. We are reporting a 6 year old girl with acute lymphoblastic leukaemia in complete remission, who was given inadvertent intrathecal Vincristine instead of Methotrexate. She developed gradually progressive quadriplegia and respiratory paralysis requiring prolonged mechanical ventilation, initially mimicking Guillain–Barre Syndrome, both clinically and electro-physiologically. She also developed progressive encephalopathy. The clinical deterioration subsequently plateaued without any significant improvement and after more than 5 months, she finally expired.

Cite

CITATION STYLE

APA

Saha, A. S., Islam, M. F., Bhattacharya, S., & Giri, P. P. (2016). Clinical Presentation of Inadvertent Intrathecal Vincristine Masquerading Guillain–Barre Syndrome. Indian Journal of Hematology and Blood Transfusion, 32, 59–61. https://doi.org/10.1007/s12288-016-0666-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free